The Senior Leadership is responsible for the overall planning and operations of the programs and activities of the Robert H. Lurie Comprehensive Cancer Center. The Senior Leadership is comprised of the Director, Deputy Director and eight Associate Directors and has undergone a number of changes during the current project period. Dr. Steven Rosen has continued as Director since 1989. Recruitment for the position of Deputy Director, proposed and approved at the time of the last site visit, was successfully completed in May, 2002 with the recruitment of Leonidas Platanias, MD, PhD, from the University of Illinois. Leadership of the three research divisions has changed during this period as well. In August, 2002, Teresa Woodruff, PhD assumed the position of Associate Director for Basic Sciences Research replacing Dr. J. Douglas Engel who left Northwestern. In September, 2004, Susan Gapstur, PhD, assumed the position of Associate Director for Cancer Prevention and Control Research, replacing Dr. Philip Greenland. This change reflected recommendations of the last site visit team for more focused expertise in this division. In March, 2006, Jonathan Licht, MD, replaced Dr. Leo Gordon as Chief of Hematology/Oncology and was appointed simultaneously as Associate Director for Clinical Sciences Research. The Associate Director for Education, Mary Kathleen Rundell, PhD, and Associate Director for Administration, Mr. Timothy Volpe remain unchanged. In addition to the five major operating divisions of the Cancer Center headed by these Associate Directors, three new Associate Director positions have been added. Based on recommendations of the last site visit team and input from Internal and External Advisory Boards for increased emphasis on translational research, the position of Associate Director for Translational Research was established and Jill C. Pelling, PhD was recruited in August, 2004 from the University of Kansas Medical Center. In response to significant growth, two other Associate Director positions were established in April, 2003. Al B. Benson, III, MD serves as Associate Director for Clinical Investigations overseeing the Center's clinical trials affiliate network, and Julian Schink, MD serves as Associate Director for Clinical Affairs, directing the Clinical Cancer Center. CCSG support is not requested for the Associate Directors for Clinical Investigations and Clinical Affairs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA060553-16
Application #
7920974
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
16
Fiscal Year
2009
Total Cost
$589,821
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Buglak, Nicholas E; Jiang, Wulin; Bahnson, Edward S M (2018) Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats. Redox Biol 19:166-178
Yang, Ruiguo; LemaƮtre, Vincent; Huang, Changjin et al. (2018) Monoclonal Cell Line Generation and CRISPR/Cas9 Manipulation via Single-Cell Electroporation. Small 14:e1702495
Takahashi, Satoe; Sun, Willy; Zhou, Yingjie et al. (2018) Prestin Contributes to Membrane Compartmentalization and Is Required for Normal Innervation of Outer Hair Cells. Front Cell Neurosci 12:211
Zheng, Jianbin; Chen, Long; Skinner, Owen S et al. (2018) ?-Glucocerebrosidase Modulators Promote Dimerization of ?-Glucocerebrosidase and Reveal an Allosteric Binding Site. J Am Chem Soc 140:5914-5924
Kenney, Grace E; Dassama, Laura M K; Pandelia, Maria-Eirini et al. (2018) The biosynthesis of methanobactin. Science 359:1411-1416
Joyce, Brian T; Zheng, Yinan; Zhang, Zhou et al. (2018) miRNA-Processing Gene Methylation and Cancer Risk. Cancer Epidemiol Biomarkers Prev 27:550-557
Chu, Lan H; Indramohan, Mohanalaxmi; Ratsimandresy, Rojo A et al. (2018) The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat Commun 9:996
Symes, Yael R; Barrington, Clare; Austin, Jane et al. (2018) Advice to patients undergoing stem cell transplant: Content analysis of survivor peer support narratives. J Health Psychol 23:818-828
Lewis, Phillip L; Green, Richard M; Shah, Ramille N (2018) 3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression. Acta Biomater 69:63-70
Ugolkov, Andrey V; Bondarenko, Gennadiy I; Dubrovskyi, Oleksii et al. (2018) 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma. Anticancer Drugs 29:717-724

Showing the most recent 10 out of 1972 publications